Andre Feldman

Prof. Andre Feldman

REDEDOR SAO LUIZ ITAIM, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2017 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
AFAndre Feldman
Andre Feldman
DMDalmo Antonio Ribeiro Moreira
Dalmo Antonio Ribeiro Moreira
CGCarlos Gun
Carlos Gun
HWHui Tzu Lin Wang
Hui Tzu Lin Wang
MHMario Hiroyuki Hirata
Mario Hiroyuki Hirata
PFPedro Farsky
Pedro Farsky

Verified
Journal Article
Open access
PDF file
RMRenata Moll-Bernardes
Renata Moll-Bernardes
SFSérgio C. Fortier
Sérgio C. Fortier
Andrea Silvestre de SousaAndrea Silvestre de Sousa
Andrea Silvestre de Sousa
RLRenato D. Lopes
Renato D. Lopes
NVNarendra Vera-Nuñez
Narendra Vera-Nuñez
EMEmiliano Medei
Emiliano Medei
Cardiovascular comorbidities and immune-response dysregulation are associated with COVID-19 severity. We aimed to explore the key immune cell profile and understand its association with disease progression in 156 patients with hypertension that were hospitalized due to COVID-19. The primary outcome was progression to severe disease. The probability of progression to severe disease was estimated using a logistic regression model that included clinical variables and immune cell subsets associated with the primary outcome. Obesity; diabetes; oxygen saturation; lung involvement on computed tomography (CT) examination; the C-reactive protein concentration; total lymphocyte count; proportions of CD4+ and CD8+ T cells; CD4/CD8 ratio; CD8+ HLA-DR MFI; and CD8+ NKG2A MFI on admission were all associated with progression to severe COVID-19. This study demonstrated that increased CD8+ NKG2A MFI at hospital admission, in combination with some clinical variables, is associated with a high risk of COVID-19 progression in hypertensive patients. These findings reinforce the hypothesis of the functional exhaustion of T cells with the increased expression of NKG2A in patients with severe COVID-19, elucidating how severe acute respiratory syndrome coronavirus 2 infection may break down the innate antiviral immune response at an early stage of the disease, with future potential therapeutic implications.

1 January 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
EMEmiliano Medei
Emiliano Medei
RMRenata Moll-Bernardes
Renata Moll-Bernardes
MPMartha V. T. Pinheiro
Martha V. T. Pinheiro
ASAndréa S. Sousa
Andréa S. Sousa
BABarbara Abufaiad
Barbara Abufaiad
OSOlga F. Souza
Olga F. Souza
Background Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, and its presentation differs according to age and sex. Recent studies have revealed differences in AF among various demographic groups, including the Latin American population. Objectives To better understand potential disparities in AF prevalence and treatment strategies in the Brazilian population through data from a large multicentric prospective registry. Methods The Rede D’Or AF registry is a multicenter prospective observational study including patients aged ≥ 18 years with AF who were seen in the emergency department of 32 tertiary hospitals in Brazil. Patients were characterized according to sex and other baseline characteristics and were classified according to previous anticoagulant use. The lack of anticoagulant use in patients with previous indications was analyzed. Statistical significance was set at 5%. Results The study data were from a total of 1955 patients enrolled. Male sex was more prevalent, and men were younger than the women. Due to an increased prevalence of previous AF episode and a higher CHA2DS2-VASc score, more women had indications for anticoagulant therapy; however, a significant proportion was not receiving this treatment. From 29 in-hospital deaths, 15 patients had previous indication for anticoagulation, but only 3 were using anticoagulants. Conclusion This study revealed sex-related differences in the Brazilian population of patients with AF that are consistent with trends in high-income countries. The promotion of better implementation of anticoagulant and antithrombotic therapies to reduce the risk of death and thromboembolic events among women with AF in Brazil is crucial.

10 May 2016 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
AFAndre Feldman
Andre Feldman
CMCésar Augusto Guimarães Marcelino
César Augusto Guimarães Marcelino
LPLayse Beneli Prado
Layse Beneli Prado
CFCarine Cristiane Fusco
Carine Cristiane Fusco
MAMara Nogueira de Araújo
Mara Nogueira de Araújo
AAAntônio Flávio Sanchez Almeida
Antônio Flávio Sanchez Almeida

15 January 2021 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Closed access
PDF file
FLFabio Augusto De Luca
Fabio Augusto De Luca
GAGuilherme Arruda
Guilherme Arruda
VEVinicius Esteves
Vinicius Esteves
AFAndre Feldman
Andre Feldman
ÍSÍtalo Bruno dos Santos Sousa
Ítalo Bruno dos Santos Sousa
OSOlga Ferreira de Souza
Olga Ferreira de Souza
Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– Different [...] Introduction The global pandemic caused by the new coronavirus (COVID-19) has been promoting major challenges and unprecedented clinical decisions in the medical scenario. Currently, according to the World Health Organization, the disease affects over 185 countries, with over 12 million people infected and nearly 500 thousand deaths. Among the most serious manifestations of the syndrome, the high prevalence of thromboembolic events, up to 31% of the patients hospitalized in intensive care units, according to an international series, calls attention.– Different

6 November 2020 in Journal of Cardiac Arrhythmias
Verified
Journal Article
Open access
AFAndre Feldman
Andre Feldman
GAGuilherme D’Andréa Saba Arruda
Guilherme D’Andréa Saba Arruda
OSOlga Ferreira de Souza
Olga Ferreira de Souza
COVID-19 is a new disease caused by the Sars-CoV-2 virus and the vast majority of patients have symptoms similar to a flu-like syndrome. A small portion of those infected ends up being hospitalized and may develop with the most severe presentation of the disease. Data from Chinese series report that hypertension appears to be a condition that imposes a greater risk of unfavorable evolution of patients. Some studies have reported that Sars-CoV-2 uses the angiotensin-converting enzyme to access its target cells. There are theories that differ about the protective or harmful role that drugs that act in the renin angiotensin aldosterone system in these patients. A British study suggests that patients using angiotensin-converting enzyme inhibitors had a lower incidence of severe forms of the disease. Another study carried out a retrospective and multicenter analysis showing that mortality was lower in the group that had used the drugs when compared to the other group (3,7 vs. 9,8%; p=0,01). The various hypotheses raised through pathophysiology are not yet able to really predict the best course of action for patients using drugs that act on the renin angiotensin system. Thus, a randomized study becomes important to try to answer definitively and with a high degree of reliability to this question.